Omega-3 index and prognosis in acute coronary chest pain patients with a low dietary intake of omega-3

Fuente, Ricardo León de la; Naesgaard, Patrycja A; Nilsen, Stein Tore; Woie, Leik; Aarsland, Torbjørn; Gundersen, Thomas E.; Nilsen, Dennis W.T.

doi:10.3109/14017431.2012.747220

Cited by 4 publications

(3 citation statements)

References 72 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There is a strong association of dietary, circulating, and supplement fatty acids with coronary risks [ 163 ]. The Omega-3 Index (eicosapentaenoic acid + docosahexaenoic acid) content in red blood cell membranes is well-confirmed novel risk marker for cardiac death [ 137 ]. More often, Omega-3 Index and prognosis are used in finding acute coronary chest pain with a low dietary intake of omega-3 fatty acids in patients [ 137 ].…”

Section: Anatomical Markersmentioning

confidence: 99%

“…The Omega-3 Index (eicosapentaenoic acid + docosahexaenoic acid) content in red blood cell membranes is well-confirmed novel risk marker for cardiac death [ 137 ]. More often, Omega-3 Index and prognosis are used in finding acute coronary chest pain with a low dietary intake of omega-3 fatty acids in patients [ 137 ]. It is also used to predict all-cause mortality due to sudden cardiac death following hospitalization with an acute coronary syndrome (ACS).…”

Section: Anatomical Markersmentioning

confidence: 99%

“…It is also used to predict all-cause mortality due to sudden cardiac death following hospitalization with an acute coronary syndrome (ACS). More specifically, arachidonic acid (AA) is used in risk assessment [ 137 ] in a population with a low intake of fish and fish oils, but adjusted Omega-3 Index did not predict fatal events following hospitalization in patients with acute chest pain and suspected ACS [ 137 ]. Various fatty acids also work as biomarkers in coronary heart diseases.…”

Section: Anatomical Markersmentioning

confidence: 99%

See 2 more Smart Citations

Emerging Risk Biomarkers in Cardiovascular Diseases and Disorders

2015

View full text Add to dashboard Cite

Present review article highlights various cardiovascular risk prediction biomarkers by incorporating both traditional risk factors to be used as diagnostic markers and recent technologically generated diagnostic and therapeutic markers. This paper explains traditional biomarkers such as lipid profile, glucose, and hormone level and physiological biomarkers based on measurement of levels of important biomolecules such as serum ferritin, triglyceride to HDLp (high density lipoproteins) ratio, lipophorin-cholesterol ratio, lipid-lipophorin ratio, LDL cholesterol level, HDLp and apolipoprotein levels, lipophorins and LTPs ratio, sphingolipids, Omega-3 Index, and ST2 level. In addition, immunohistochemical, oxidative stress, inflammatory, anatomical, imaging, genetic, and therapeutic biomarkers have been explained in detail with their investigational specifications. Many of these biomarkers, alone or in combination, can play important role in prediction of risks, its types, and status of morbidity. As emerging risks are found to be affiliated with minor and microlevel factors and its diagnosis at an earlier stage could find CVD, hence, there is an urgent need of new more authentic, appropriate, and reliable diagnostic and therapeutic markers to confirm disease well in time to start the clinical aid to the patients. Present review aims to discuss new emerging biomarkers that could facilitate more authentic and fast diagnosis of CVDs, HF (heart failures), and various lipid abnormalities and disorders in the future.

show abstract

Section: Anatomical Markersmentioning

confidence: 99%

Section: Anatomical Markersmentioning

confidence: 99%

Section: Anatomical Markersmentioning

confidence: 99%

See 1 more Smart Citation

Emerging Risk Biomarkers in Cardiovascular Diseases and Disorders

2015

View full text Add to dashboard Cite

show abstract

Secreted phospholipase A2 inhibitor modulates fatty acid composition and reduces obesity-induced inflammation in Beagle dogs

Bourgeois²,

Vandermeulen

et al. 2015

The Veterinary Journal

View full text Add to dashboard Cite

Seafood Long-Chain n-3 Polyunsaturated Fatty Acids and Cardiovascular Disease: A Science Advisory From the American Heart Association

Rimm¹,

Appel²,

Chiuve³

et al. 2018

Circulation

400

240

View full text Add to dashboard Cite

Since the 2002 American Heart Association scientific statement "Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease," evidence from observational and experimental studies and from randomized controlled trials continues to emerge to further substantiate the beneficial effects of seafood long-chain n-3 polyunsaturated fatty acids and cardiovascular disease. A recent American Heart Association science advisory addressed the specific effect of n-3 polyunsaturated fatty acid supplementation on clinical cardiovascular events. This American Heart Association science advisory extends that review and offers further support to include n-3 polyunsaturated fatty acids from seafood consumption. Several potential mechanisms have been investigated, including antiarrhythmic, anti-inflammatory, hematologic, and endothelial, although for most, longer-term dietary trials of seafood are warranted to substantiate the benefit of seafood as a replacement for other important sources of macronutrients. The present science advisory reviews this evidence and makes a suggestion in the context of the and in consideration of other constituents of seafood and the impact on sustainability. We conclude that 1 to 2 seafood meals per week be included to reduce the risk of congestive heart failure, coronary heart disease, ischemic stroke, and sudden cardiac death, especially when seafood replaces the intake of less healthy foods.

show abstract

Omega-3 index and prognosis in acute coronary chest pain patients with a low dietary intake of omega-3

Abstract: In a population with a low intake of fish and fish oils, the adjusted omega-3 index did not predict fatal events following hospitalization in patients with acute chest pain and suspected ACS.

Cited by 4 publications

References 72 publications

Emerging Risk Biomarkers in Cardiovascular Diseases and Disorders

Emerging Risk Biomarkers in Cardiovascular Diseases and Disorders

Secreted phospholipase A2 inhibitor modulates fatty acid composition and reduces obesity-induced inflammation in Beagle dogs

Seafood Long-Chain n-3 Polyunsaturated Fatty Acids and Cardiovascular Disease: A Science Advisory From the American Heart Association

Contact Info

Product

Resources

About